Mitsubishi UFJ Trust & Banking’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Sell |
100,026
-14,782
| -13% | -$1.86M | 0.03% | 491 |
|
|
2025
Q1 | $12.7M | Sell |
114,808
-6,334
| -5% | -$701K | 0.03% | 479 |
|
|
2024
Q4 | $16.5M | Sell |
121,142
-4,578
| -4% | -$625K | 0.04% | 428 |
|
|
2024
Q3 | $14.5M | Buy |
125,720
+811
| +0.6% | +$93.4K | 0.03% | 494 |
|
|
2024
Q2 | $17.2M | Buy |
124,909
+12,191
| +11% | +$1.68M | 0.04% | 416 |
|
|
2024
Q1 | $15.5M | Sell |
112,718
-4,509
| -4% | -$622K | 0.04% | 464 |
|
|
2023
Q4 | $15.4M | Buy |
117,227
+18,687
| +19% | +$2.46M | 0.04% | 453 |
|
|
2023
Q3 | $11.1M | Sell |
98,540
-481
| -0.5% | -$54.1K | 0.03% | 510 |
|
|
2023
Q2 | $9.34M | Buy |
99,021
+9,208
| +10% | +$868K | 0.02% | 563 |
|
|
2023
Q1 | $9.09M | Buy |
89,813
+9,330
| +12% | +$944K | 0.02% | 569 |
|
|
2022
Q4 | $9.61M | Buy |
80,483
+2,039
| +3% | +$244K | 0.03% | 554 |
|
|
2022
Q3 | $8.33M | Sell |
78,444
-29,938
| -28% | -$3.18M | 0.02% | 562 |
|
|
2022
Q2 | $10.6M | Buy |
108,382
+24,344
| +29% | +$2.37M | 0.03% | 532 |
|
|
2022
Q1 | $7.88M | Sell |
84,038
-12,335
| -13% | -$1.16M | 0.02% | 624 |
|
|
2021
Q4 | $8.21M | Buy |
96,373
+34,348
| +55% | +$2.93M | 0.02% | 637 |
|
|
2021
Q3 | $5.95M | Sell |
62,025
-1,421
| -2% | -$136K | 0.01% | 716 |
|
|
2021
Q2 | $6.18M | Buy |
63,446
+6,153
| +11% | +$599K | 0.01% | 724 |
|
|
2021
Q1 | $5.57M | Sell |
57,293
-12,631
| -18% | -$1.23M | 0.01% | 713 |
|
|
2020
Q4 | $6.7M | Sell |
69,924
-1,862
| -3% | -$178K | 0.01% | 700 |
|
|
2020
Q3 | $6.9M | Buy |
71,786
+2,381
| +3% | +$229K | 0.02% | 658 |
|
|
2020
Q2 | $8.47M | Sell |
69,405
-222
| -0.3% | -$27.1K | 0.02% | 591 |
|
|
2020
Q1 | $6.03M | Buy |
69,627
+5,292
| +8% | +$458K | 0.02% | 617 |
|
|
2019
Q4 | $6.92M | Buy |
+64,335
| New | +$6.92M | 0.02% | 684 |
|